Home » Newsletters » BioWorld Science

BioWorld Science

March 12, 1999

View Archived Issues

NCI to conduct further testing of Lorus anticancer compounds

Genzyme General: Q4 and year-end 1998 highlights

Xoma continues patient enrollment in phase III meningococcemia trial

Techniclone enters licensing agreement for Oncolym with Schering AG

New U.S. patent broadens the base of ImmunoGen's TAP technology

Roberts acquires Lodine rights in the U.K. and Ireland

Amgen and Praecis to develop and commercialize abarelix

Hyseq: Q4 and year-end 1998 highlights

ImClone receives milestone payment for C225 clinical advance

U.K. is country of first launch for Schering-Plough's oral alkylating agent

Kynurenine 3-monooxygenase inhibitors for neurodegenerative disorders

Dual vasopeptidase inhibitor omapatrilat reduces blood pressure in healthy volunteers

Warner-Lambert prepares irreversible tyrosine kinase inhibitors

GABA-A alpha5 subunit-selective inverse agonists from Merck useful for Alzheimer's disease

Recordati claims potent and selective 5-HT1A receptor antagonists for urinary disorders

Orally active, selective V2 agonists in development at AHP

FDA okays new indication and minimal liver function testing for Lescol

Ad.VEGF121 preserves blood flow to ischemic tissues in animal models

Sonus adds new patent to its ultrasound contrast agent portfolio

ACC highlights: UT-15 effective and safe in severe intermittent claudication

Biosense and RPR Gencell to develop innovative gene therapy to treat heart disease

Sangamo enters agreement with Japan Tobacco for validation of novel gene targets

Genentech reports results on TNK-tPA from TIMI 10B and ASSENT 1 at ACC meeting

Procept's PRO-2000 Gel shows positive results in protection from HIV infection

Diltiazem plus aspirin for secondary prevention following thrombolysis in MI patients

FDA grants fast track designation for pneumococcal conjugate vaccine

LU-135252 may be useful in AMI patients according to data presented at ACC meeting

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...